Katharine Grabek is a co-founder of Fauna Bio, a biotech company in Berkeley, CA, that is focused on translating discoveries from animal genomics into human therapies. Katharine’s doctoral and post-doctoral research focused on understanding the evolutionary and genetic mechanisms that underlie mammalian hibernation. She utilized proteomic, transcriptomic and genomic approaches to link the 13-lined ground squirrel’s genome to phenome. She received her PhD in human medical genetics at the University of Colorado Anschutz Medical Campus, where she completed her thesis research on hibernation in Dr. Sandy Martin’s lab. Before founding Fauna Bio, Katharine completed her postdoctoral training in Dr. Carlos Bustamante’s lab in the Department of Biomedical Data Science at Stanford University.